Skip to content
zameds

Ethinylestradiol, gestodene

Sold as Melodene, Nessifem, Actordene, Carmadene, Dyolafem, Gestodene/ethinylestradiol forrester, Minulette, Femodene ed

S3Read from the PI-PIL document and verified

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
4
Registrations
8
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Bayer (Pty) Ltd û IsandoCertificate held by Bayer (Pty) LtdMelodene, Femodene ed0.02 mg/0.075 mg, 0,03 mg/0,075 mg310462, W0098S3PIPIL
Cipla Medpro (Pty) LtdNessifem, Actordene, CarmadeneNot stated470344, 481352, 481353Not determinedNone
Forrester Pharma (Pty) LtdDyolafem, Gestodene/ethinylestradiol forrester0,075/0,02 MG521019, 521020Not determinedNone
Pfizer Laboratories (Pty) LtdMinulette30ug, 75ugW0011Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Melodene

EACH TABLET CONTAINS ETHINYLESTRADIOL 0,02 mg GESTODENE 0,075 mg

0.02 mg/0.075 mgCoated tablets31046231/18.8/0462Approved 20 May 2022RegisteredS3PIPIL
Nessifem

Each active tablet contains GESTODENE 60,0 mcg and ETHINYLESTRADIOL 15,0 mcg

Not listed47034447/18.8/0344RegisteredNot determinedNone
Actordene

Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,02 mg

Not listed48135248/18.8/1352RegisteredNot determinedNone
Carmadene

Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,03 mg

Not listed48135348/18.8/1353RegisteredNot determinedNone
Dyolafem

Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,030 mg

Not listed52101952/18.8/1019RegisteredNot determinedNone
Gestodene/ethinylestradiol 0,075/0,02 MG forrester

Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,020 mg

0,075/0,02 MG52102052/18.8/1020RegisteredNot determinedNone
Minulette

EACH TABLET CONTAINS ETHINYLESTRADIOL 0,030 mg GESTODENE 0,75 mg

30ug. 75ugTabletW0011W/18.8/11Approved 4 October 2021RegisteredNot determinedPIPIL
Femodene ed

EACH TABLET CONTAINS ETHINYLESTRADIOL 0,030 mg GESTODENE 0,75 mg

0,03 mg/0,075 mgCoated tablets.W0098W/21.8.2/98Approved 20 May 2022RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Melodene, Bayer (Pty) Ltd û Isando is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles